Metallo-β-lactamase expression confers an advantage to Pseudomonas aeruginosa isolates compared with other β-lactam resistance mechanisms, favoring the prevalence of metallo-β-lactamase producers in a clinical environment

Microbial Drug Resistance

Volumn 16, Issue 3, 2010, Pages 223-230

  Corich, Lucia ^a   Dolzani, Lucilla ^a   Tonin, Enrico A ^a   Vitali, Luca A ^b   Lagatolla, Cristina ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFTAZIDIME; CETRIMIDE; CHLORHEXIDINE; CLOXACILLIN; GENTAMICIN; IMIPENEM; KANAMYCIN; MERCURIC CHLORIDE; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; PORIN; SPECTINOMYCIN; STREPTOMYCIN; TOBRAMYCIN;

ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIUM ISOLATE; HOSPITAL; INTEGRON; ITALY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; DNA, BACTERIAL; GENOTYPE; HUMANS; INTEGRONS; ITALY; METALLOPROTEINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PORINS; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

PSEUDOMONAS AERUGINOSA;

EID: 77956569701     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2010.0016     Document Type: Article

References (31)

1. Andersson, D.I. 2003. Persistence of antibiotic resistant bacteria. Curr. Opin. Microbiol. 6:452-456.
2. Andersson, D.I., H.W. Van Verseveld, A.H. Stouthamer, and C.G. Kurland. 1986. Suboptimal growth with hyper-accurate ribosomes. Arch. Microbiol. 144:96-101.
3. Billington, O.J., T.D. McHugh, and S.H. Gillespie. 1999. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43:1866-1869.
4. Castanheira, M., H.S. Sader, R.N. Jones, E. Debbia, R.C. Picao, and A.C. Gales. 2007. In71, an Enterobacter cloacae blaVIM-1-carrying integron related to In70.2 from Italian Pseudomonas aeruginosa isolates: a SENTRY Antimicrobial Surveillance Program report. Microb. Drug Resist. 13:130-134.
5. Clinical and Laboratory Standards and Institute. 2006. Performance Standards for Antimicrobial Susceptibility Testing, 16th Informational Supplement, M100-S16. CLSI, Wayne, PA.
6. Cornaglia, G., A. Mazzariol, L. Lauretti, G.M. Rossolini, and R. Fontana. 2000. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase. Clin. Infect. Dis. 31: 1119-1125.
7. Curran, B., D. Jonas, H. Grundmann, T. Pitt, and C.G. Dowson. 2004. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol. 42:5644-5649.
8. Edalucci, E., R. Spinelli, L. Dolzani, M.L. Riccio, V. Du-bois, E.A. Tonin, G.M. Rossolini, and C. Lagatolla. 2008. Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa. Clin. Microbiol. Infect. 14:88-90.
9. Gaur, A., P. Prakash, S. Anupurba, and T.M. Mohapatra. 2007. Possible role of integrase gene polymerase chain reaction as an epidemiological marker: study of multidrug-resistant Acinetobacter baumannii isolated from nosocomial infections. Int. J. Antimicrob. Agents 29:446-450.
10. Giske, C.G., B. Libisch, C. Colinon, E. Scoulica, L. Pagani, M. Fuzi, G. Kronvall, and G.M. Rossolini. 2006. Establishing clonal relationships between VIM-1-like metallo-beta-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing. J. Clin. Microbiol. 44:4309-4315.
11. Gustafsson, I., O. Cars, and D.I. Andersson. 2003. Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteers. J. Antimicrob. Chemother. 52:258-263.
12. Kholodii, G.Y., O.V. Yurieva, O.L. Lomovskaya, Z. Gor-lenko, S.Z. Mindlin, and V.G. Nikiforov. 1993. Tn5053, a mercury resistance transposon with integron's ends. J. Mol. Biol. 230:1103-1107.
13. Lagatolla, C., E. Edalucci, L. Dolzani, M.L. Riccio, F. De Luca, E. Medessi, G.M. Rossolini, and E.A. Tonin. 2006. Molecular evolution of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity. J. Clin. Microbiol. 44:2348-2353.
14. Lagatolla, C., E.A. Tonin, C. Monti-Bragadin, L. Dolzani, F. Gombac, C. Bearzi, E. Edalucci, F. Gionechetti, and G.M. Rossolini. 2004. Endemic carbapenem-resistant Pseu-domonas aeruginosa with acquired metallo-beta- lactamase determinants in European hospital. Emerg. Infect. Dis. 10:535-538.
15. Lauretti, L., M.L. Riccio, A. Mazzariol, G. Cornaglia, G. Amicosante, R. Fontana, and G.M. Rossolini. 1999. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.
16. Lee, M.D., S. Sanchez, M. Zimmer, U. Idris, M.E. Berrang, and P.F. McDermott. 2002. Class 1 integron-associated tobramycin-gentamicin resistance in Campylobacter jejuni isolated from the broiler chicken house environment. Anti-microb. Agents Chemother. 46:3660-3664.
17. Lenski, R.E. 1997. The cost of antibiotic resistance\from the perspective of a bacterium. Ciba Found. Symp. 207:131-140; discussion 141-151.
18. Levesque, C., L. Piche, C. Larose, and P.H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39: 185-191.
19. Levesque, C., S. Brassard, J. Lapointe, and P.H. Roy. 1994. Diversity and relative strength of tandem promoters for the antibiotic-resistance genes of several integrons. Gene 142:49-54.
20. Mikkola, R., and C.G. Kurland. 1992. Selection of laboratory wild-type phenotype from natural isolates of Escherichia coli in chemostats. Mol. Biol. Evol. 9:394-402.
21. Nakahara, H., and H. Kozukue. 1982. Isolation of chlor-hexidine-resistant Pseudomonas aeruginosa from clinical lesions. J. Clin. Microbiol. 15:166-168.
22. Negri, M.C., M. Lipsitch, J. Blazquez, B.R. Levin, and F. Baquero. 2000. Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance. Antimicrob. Agents Chemother. 44: 2485-2491.
23. Nguyen, T.N., Q.G. Phan, L.P. Duong, K.P. Bertrand, and R.E. Lenski. 1989. Effects of carriage and expression of the Tn10 tetracycline-resistance operon on the fitness of Escher-ichia coli K12. Mol. Biol. Evol. 6:213-225.
24. Poirel, L., G.F. Weldhagen, C. De Champs, and P. Nordmann. 2002. A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum beta-lactamase GES-2 in South Africa. J. Antimicrob. Chemother. 49:561-565.
25. Riccio, M.L., L. Pallecchi, J.D. Docquier, S. Cresti, M.R. Catania, L. Pagani, C. Lagatolla, G. Cornaglia, R. Fontana, and G.M. Rossolini. 2005. Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudo-monas aeruginosa strains producing the VIM-1 metallo-{beta}-lactamase from different Italian hospitals. Antimicrob. Agents Chemother. 49:104-110.
26. Rodriguez-Martinez, J.M., L. Poirel, and P. Nordmann. 2009. Extended-spectrum cephalosporinases in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53:1766-1771.
27. Sander, P., B. Springer, T. Prammananan, A. Sturmfels, M. Kappler, M. Pletschette, and E.C. Bottger. 2002. Fitness cost of chromosomal drug resistance-conferring mutations. An-timicrob. Agents Chemother. 46:1204-1211.
28. Severino, P., and V.D. Magalhaes. 2004. Integrons as tools for epidemiological studies. Clin. Microbiol. Infect. 10: 156-162.
29. Shaw, K.J., P.N. Rather, R.S. Hare, and G.H. Miller. 1993. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57:138-163.
30. Tsakris, A., S. Pournaras, N. Woodford, M.F. Palepou, G.S. Babini, J. Douboyas, and D.M. Livermore. 2000. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38: 1290-1292.
31. Ward, H., G.G. Perron, and R.C. Maclean. 2009. The cost of multiple drug resistance in Pseudomonas aeruginosa. J. Evol. Biol. 22:997-1003.